Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Respiratory Medicine|October 22, 2011
A comparative study on endobronchial ultrasound-guided and fluoroscopic-guided transbronchial lung biopsy of peripheral pulmonary lesionsNadja Triller, Jasmina Dimitrijevic, Ales Rozman
Journal of Telemedicine and Telecare|December 22, 2011
Telecytology for rapid assessment of cytological specimensIzidor Kern, Simona Gabric, Nadja Triller, et al.
Respiration; International Review of Thoracic Diseases|January 6, 2009
Flexible bronchoscope damage and repair costs in a bronchoscopy teaching unitAles Rozman, Stefan Duh, Marija Petrinec-Primozic, et al.
Lung Cancer (Amsterdam, Netherlands)|August 29, 2006
Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed diseaseNadja Triller, Peter Korosec, Izidor Kern, et al.
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|October 15, 2008
Skin metastases of lung cancerKatja Triller Vadnal, Nadja Triller, Igor Pozek, et al.
Respirology (Carlton, Vic.)|February 20, 2013
Rigid versus semi-rigid thoracoscopy for the diagnosis of pleural disease: a randomized pilot studyAles Rozman, Luka Camlek, Mateja Marc-Malovrh, et al.
Respiration; International Review of Thoracic Diseases|November 19, 2005
Music during bronchoscopic examination: the physiological effects. A randomized trialNadja Triller, Damjan Erzen, Stefan Duh, et al.
Radiology and Oncology|August 31, 2012
Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical settingMirko Lekic, Viljem Kovac, Nadja Triller, et al.
Pathology Oncology Research : POR|April 2, 2011
Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patientsMatija Rijavec, Mira Silar, Nadja Triller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancerWolfram Brugger, Nadja Triller, Maria Blasinska-Morawiec, et al.
Pageof 1